Literature DB >> 26711871

Response.

Driss Ait Ouakrim1, S Ghazaleh Dashti1, Aung Ko Win2.   

Abstract

Mesh：

Substances：

Year:  2015        PMID： 26711871      PMCID： PMC4907360          DOI： 10.1093/jnci/djv385

Source DB:  PubMed          Journal:  J Natl Cancer Inst        ISSN： 0027-8874            Impact factor:   13.506


× No keyword cloud information.
  3 in total

1.  Aspirin, Ibuprofen, and the Risk of Colorectal Cancer in Lynch Syndrome.

Authors:  Driss Ait Ouakrim; Seyedeh Ghazaleh Dashti; Rowena Chau; Daniel D Buchanan; Mark Clendenning; Christophe Rosty; Ingrid M Winship; Joanne P Young; Graham G Giles; Barbara Leggett; Finlay A Macrae; Dennis J Ahnen; Graham Casey; Steven Gallinger; Robert W Haile; Loïc Le Marchand; Stephen N Thibodeau; Noralane M Lindor; Polly A Newcomb; John D Potter; John A Baron; John L Hopper; Mark A Jenkins; Aung Ko Win
Journal:  J Natl Cancer Inst       Date:  2015-06-24       Impact factor: 13.506

2.  Long-term effect of aspirin on cancer risk in carriers of hereditary colorectal cancer: an analysis from the CAPP2 randomised controlled trial.

Authors:  John Burn; Anne-Marie Gerdes; Finlay Macrae; Jukka-Pekka Mecklin; Gabriela Moeslein; Sylviane Olschwang; Diane Eccles; D Gareth Evans; Eamonn R Maher; Lucio Bertario; Marie-Luise Bisgaard; Malcolm G Dunlop; Judy W C Ho; Shirley V Hodgson; Annika Lindblom; Jan Lubinski; Patrick J Morrison; Victoria Murday; Raj Ramesar; Lucy Side; Rodney J Scott; Huw J W Thomas; Hans F Vasen; Gail Barker; Gillian Crawford; Faye Elliott; Mohammad Movahedi; Kirsi Pylvanainen; Juul T Wijnen; Riccardo Fodde; Henry T Lynch; John C Mathers; D Timothy Bishop
Journal:  Lancet       Date:  2011-10-27       Impact factor: 79.321

Review 3.  Estimates of benefits and harms of prophylactic use of aspirin in the general population.

Authors:  J Cuzick; M A Thorat; C Bosetti; P H Brown; J Burn; N R Cook; L G Ford; E J Jacobs; J A Jankowski; C La Vecchia; M Law; F Meyskens; P M Rothwell; H J Senn; A Umar
Journal:  Ann Oncol       Date:  2014-08-05       Impact factor: 32.976
  3 in total
  1 in total

1.  Type 2 diabetes mellitus, blood cholesterol, triglyceride and colorectal cancer risk in Lynch syndrome.

Authors:  S Ghazaleh Dashti; Wing Yan Li; Daniel D Buchanan; Mark Clendenning; Christophe Rosty; Ingrid M Winship; Finlay A Macrae; Graham G Giles; Sheetal Hardikar; Xinwei Hua; Stephen N Thibodeau; Jane C Figueiredo; Graham Casey; Robert W Haile; Steven Gallinger; Loïc Le Marchand; Polly A Newcomb; John D Potter; Noralane M Lindor; John L Hopper; Mark A Jenkins; Aung Ko Win
Journal:  Br J Cancer       Date:  2019-09-25       Impact factor: 7.640
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.